JP2008506632A5 - - Google Patents

Download PDF

Info

Publication number
JP2008506632A5
JP2008506632A5 JP2006554374A JP2006554374A JP2008506632A5 JP 2008506632 A5 JP2008506632 A5 JP 2008506632A5 JP 2006554374 A JP2006554374 A JP 2006554374A JP 2006554374 A JP2006554374 A JP 2006554374A JP 2008506632 A5 JP2008506632 A5 JP 2008506632A5
Authority
JP
Japan
Prior art keywords
trp
azagly
asn
tyr
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006554374A
Other languages
English (en)
Japanese (ja)
Other versions
JP4346650B2 (ja
JP2008506632A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2005/012021 external-priority patent/WO2006001499A2/en
Publication of JP2008506632A publication Critical patent/JP2008506632A/ja
Publication of JP2008506632A5 publication Critical patent/JP2008506632A5/ja
Application granted granted Critical
Publication of JP4346650B2 publication Critical patent/JP4346650B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006554374A 2004-06-25 2005-06-23 メタスチン誘導体およびその用途 Expired - Fee Related JP4346650B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004187671 2004-06-25
JP2004363311 2004-12-15
PCT/JP2005/012021 WO2006001499A2 (en) 2004-06-25 2005-06-23 Metastin derivatives and use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008245073A Division JP4654284B2 (ja) 2004-06-25 2008-09-25 メタスチン誘導体およびその用途

Publications (3)

Publication Number Publication Date
JP2008506632A JP2008506632A (ja) 2008-03-06
JP2008506632A5 true JP2008506632A5 (cg-RX-API-DMAC10.html) 2008-11-13
JP4346650B2 JP4346650B2 (ja) 2009-10-21

Family

ID=34971534

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2006554374A Expired - Fee Related JP4346650B2 (ja) 2004-06-25 2005-06-23 メタスチン誘導体およびその用途
JP2008245073A Expired - Fee Related JP4654284B2 (ja) 2004-06-25 2008-09-25 メタスチン誘導体およびその用途
JP2009132363A Pending JP2009227687A (ja) 2004-06-25 2009-06-01 メタスチン誘導体およびその用途

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2008245073A Expired - Fee Related JP4654284B2 (ja) 2004-06-25 2008-09-25 メタスチン誘導体およびその用途
JP2009132363A Pending JP2009227687A (ja) 2004-06-25 2009-06-01 メタスチン誘導体およびその用途

Country Status (20)

Country Link
US (2) US7625869B2 (cg-RX-API-DMAC10.html)
EP (2) EP1758932A2 (cg-RX-API-DMAC10.html)
JP (3) JP4346650B2 (cg-RX-API-DMAC10.html)
CN (2) CN101863971A (cg-RX-API-DMAC10.html)
AR (1) AR049938A1 (cg-RX-API-DMAC10.html)
AU (1) AU2005257484A1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0512397A (cg-RX-API-DMAC10.html)
CA (1) CA2571420A1 (cg-RX-API-DMAC10.html)
CL (1) CL2008003730A1 (cg-RX-API-DMAC10.html)
CR (1) CR8828A (cg-RX-API-DMAC10.html)
IL (1) IL179640A0 (cg-RX-API-DMAC10.html)
MA (1) MA28903B1 (cg-RX-API-DMAC10.html)
MX (1) MXPA06014206A (cg-RX-API-DMAC10.html)
NO (1) NO20065957L (cg-RX-API-DMAC10.html)
NZ (1) NZ552029A (cg-RX-API-DMAC10.html)
PE (2) PE20091567A1 (cg-RX-API-DMAC10.html)
RU (1) RU2006145886A (cg-RX-API-DMAC10.html)
SG (1) SG153865A1 (cg-RX-API-DMAC10.html)
TW (1) TW200607816A (cg-RX-API-DMAC10.html)
WO (1) WO2006001499A2 (cg-RX-API-DMAC10.html)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1494732E (pt) 2002-03-20 2008-03-20 Mannkind Corp Aparelho de inalação
CA2511858A1 (en) 2002-12-26 2004-07-29 Takeda Pharmaceutical Company Limited Metastin derivative and use thereof
EP1604682A4 (en) 2003-03-12 2009-06-24 Takeda Chemical Industries Ltd AGENTS IMPROVING GONADIC FUNCTION
MXPA06011580A (es) 2004-04-08 2007-05-04 Biomatrica Inc Integracion de almacenamiento de muestras y administracion de muestras para las ciencias de la vida.
JP4346650B2 (ja) 2004-06-25 2009-10-21 武田薬品工業株式会社 メタスチン誘導体およびその用途
MX2007001903A (es) 2004-08-20 2007-08-02 Mannkind Corp Catalisis de sintesis de dicetopiperazina.
KR20130066695A (ko) 2004-08-23 2013-06-20 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
KR101486397B1 (ko) 2005-09-14 2015-01-28 맨카인드 코포레이션 활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법
TWI386417B (zh) 2005-12-22 2013-02-21 Takeda Pharmaceutical 轉移抑素衍生物及其用途
US20090093615A1 (en) * 2005-12-22 2009-04-09 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
US8404643B2 (en) * 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
BRPI0707991B8 (pt) 2006-02-22 2021-05-25 Mannkind Corp métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco
US8183212B2 (en) * 2006-04-26 2012-05-22 Kyoto University Compound having GPR54 agonistic activity
ITMI20061607A1 (it) 2006-08-09 2008-02-10 Maria Vincenza Carriero Peptidi con attivita farmacologica
TWI404726B (zh) * 2006-10-25 2013-08-11 Takeda Pharmaceutical 腫瘤轉移抑制素衍生物及其用途
UA94774C2 (en) * 2006-10-25 2011-06-10 Такеда Фармасьютикал Компани Лимитед Metastin derivatives and use thereof
US20110118172A1 (en) * 2008-04-24 2011-05-19 Takeda Pharmaceutical Company Limited Metastin derivative and use thereof
WO2009139298A1 (ja) * 2008-04-30 2009-11-19 国立大学法人京都大学 メタスチン誘導体およびその用途
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
RU2608439C2 (ru) 2008-06-13 2017-01-18 Маннкайнд Корпорейшн Ингалятор для сухого порошка и система для доставки лекарственных средств
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
EP2609954B1 (en) 2008-06-20 2021-12-29 MannKind Corporation An interactive apparatus for real-time profiling of inhalation efforts
PL2314609T3 (pl) 2008-07-30 2017-07-31 Takeda Pharmaceutical Company Limited Pochodne metastyny i ich zastosowanie
PE20110939A1 (es) 2008-12-29 2012-01-19 Takeda Pharmaceutical Agente preventivo/terapeutico contra el cancer
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
WO2010137022A1 (en) 2009-05-27 2010-12-02 Yeda Research And Development Co. Ltd Gpr54 agonists or antagonists for treatment of diseases presenting behavioral abnormalities
EA020865B1 (ru) 2009-12-22 2015-02-27 Такеда Фармасьютикал Компани Лимитед Композиция с замедленным высвобождением
WO2012018639A2 (en) 2010-07-26 2012-02-09 Biomatrica, Inc. Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
US9376709B2 (en) 2010-07-26 2016-06-28 Biomatrica, Inc. Compositions for stabilizing DNA and RNA in blood and other biological samples during shipping and storage at ambient temperatures
EP2694402B1 (en) 2011-04-01 2017-03-22 MannKind Corporation Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
EP2755690B1 (en) 2011-08-04 2020-04-01 Merck Sharp & Dohme B.V. Kisspeptide-pentasaccharide conjugates
WO2013063160A1 (en) 2011-10-24 2013-05-02 Mannkind Corporation Methods and compositions for treating pain
JP2015511600A (ja) 2012-03-14 2015-04-20 イェダ リサーチ アンド ディベロップメント カンパニー リミテッド 修飾キスペプチンペプチドおよびその使用
CA2878457C (en) 2012-07-12 2021-01-19 Mannkind Corporation Dry powder drug delivery systems and methods
WO2014100755A2 (en) 2012-12-20 2014-06-26 Biomatrica, Inc. Formulations and methods for stabilizing pcr reagents
JP6143270B2 (ja) * 2013-01-31 2017-06-07 学校法人東京薬科大学 マイオスタチン阻害ペプチド
CA2918369C (en) 2013-07-18 2021-06-29 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
WO2015112703A1 (en) * 2014-01-22 2015-07-30 The Johns Hopkins University Compositions and methods for treating diabetes
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
EP3942931A1 (en) 2014-06-10 2022-01-26 Biomatrica, INC. Stabilization of thrombocytes at ambient temperatures
ES3037826T3 (en) 2015-12-08 2025-10-07 Biomatrica Inc Reduction of erythrocyte sedimentation rate
TWI855377B (zh) 2016-09-30 2024-09-11 瑞士商麥歐文科學有限公司 治療女性不孕症之方法
EP4545553A3 (en) 2017-07-05 2025-10-22 ShangPharma Innovation Inc. Peptide compound and application thereof, and composition containing peptide compound
CN108752233B (zh) * 2018-07-18 2020-10-16 河北师范大学 小分子凝胶因子、凝胶材料及制备方法和应用
US20230159450A1 (en) * 2020-05-08 2023-05-25 The Feinstein Institutes For Medical Research Dimers for use in synthesis of peptidomimetics
WO2025217074A1 (en) 2024-04-08 2025-10-16 Radionetics Oncology, Inc. Kisspeptin receptor (kiss1r) targeted therapeutics and uses thereof

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524747A (en) * 1976-05-11 1978-09-13 Ici Ltd Polypeptide
FR2488253A1 (fr) * 1980-08-08 1982-02-12 Roques Bernard Nouveaux peptides et leur application en therapeutique
IL74827A (en) * 1984-05-21 1989-06-30 Salk Inst For Biological Studi Peptides active as gnrh antagonists and pharmaceutical compositions containing them
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
CA2229201A1 (en) 1995-10-19 1997-04-24 Satoshi Sasaki Quinoline derivatives, their production and use
JPH09169735A (ja) 1995-10-19 1997-06-30 Takeda Chem Ind Ltd キノリン誘導体、その製造法および用途
JP2000510453A (ja) 1996-04-19 2000-08-15 ノボ ノルディスク アクティーゼルスカブ 成長ホルモン遊離特性を有する化合物
WO1998039448A2 (en) 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
JP4486187B2 (ja) 1998-10-27 2010-06-23 武田薬品工業株式会社 新規g蛋白質共役型レセプター蛋白質、そのdnaおよびそのリガンド
US6528054B1 (en) 1998-12-28 2003-03-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
ES2313893T3 (es) 1999-06-28 2009-03-16 ABBOTT GMBH & CO. KG Composicion para la prevencion de crecimiento tumoral.
US6638906B1 (en) 1999-12-13 2003-10-28 Nobex Corporation Amphiphilic polymers and polypeptide conjugates comprising same
CN1411509A (zh) * 1999-12-17 2003-04-16 武田药品工业株式会社 Kiss-1肽的制造方法
JP2001231581A (ja) * 1999-12-17 2001-08-28 Takeda Chem Ind Ltd KiSS−1ペプチドの製造法
CA2404233A1 (en) 2000-03-29 2001-10-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
WO2001075104A1 (fr) 2000-03-30 2001-10-11 Takeda Chemical Industries, Ltd. Nouvelle proteine, adn codant pour celle-ci, et son procede de production
US7834141B1 (en) 2000-03-31 2010-11-16 Theresa Siler-Khodr Non-mammalian GnRH analogs and uses thereof in tumor cell growth regulation and cancer therapy
RU2311920C2 (ru) 2000-09-20 2007-12-10 Корикса Корпорейшн Композиции и способы для лечения и диагностики рака легких
JP2003026601A (ja) 2000-11-29 2003-01-29 Takeda Chem Ind Ltd 医薬組成物およびその製造法
JP2002320496A (ja) 2001-02-26 2002-11-05 Takeda Chem Ind Ltd 新規マウス型KiSS−1レセプタータンパク質およびそのDNA
WO2002085399A1 (fr) 2001-04-20 2002-10-31 Takeda Chemical Industries, Ltd. Preparations contenant un peptide
EP1391518A4 (en) 2001-05-17 2006-06-28 Shimadzu Corp PROCESS FOR PEPTIDE MANUFACTURE
ATE360034T1 (de) 2001-09-19 2007-05-15 Takeda Pharmaceutical Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
US20050176091A1 (en) * 2002-01-11 2005-08-11 Takao Yamada Process for producing kiss-1 peptide
JP2003300906A (ja) 2002-04-12 2003-10-21 Daiichi Fine Chemical Co Ltd がん転移抑制因子の安定化
JPWO2004035089A1 (ja) * 2002-10-09 2006-02-09 協和醗酵工業株式会社 ホルモン依存性癌の治療剤
DE60327344D1 (de) 2002-10-25 2009-06-04 Takeda Pharmaceutical Gpr54 'knock-out' säugetiere und screening-verfahren, die sie verwenden
JP4804714B2 (ja) 2002-12-26 2011-11-02 武田薬品工業株式会社 メタスチン誘導体およびその用途
CA2511858A1 (en) * 2002-12-26 2004-07-29 Takeda Pharmaceutical Company Limited Metastin derivative and use thereof
US6800611B2 (en) * 2003-01-06 2004-10-05 Takeda Chemical Industries, Ltd. Metastin derivatives and their use
KR100595364B1 (ko) 2003-02-20 2006-07-03 재단법인 목암생명공학연구소 Lk8 단백질을 유효성분으로 포함하는 항암제
EP1604682A4 (en) 2003-03-12 2009-06-24 Takeda Chemical Industries Ltd AGENTS IMPROVING GONADIC FUNCTION
EP1464652A1 (en) 2003-04-02 2004-10-06 Institut National De La Sante Et De La Recherche Medicale (Inserm) GPR54 receptor agonist and antagonist useful for the treatment of gonadotropin related diseases
US20050002935A1 (en) 2003-04-17 2005-01-06 Vincent Ling Use of B7-H3 as an immunoregulatory agent
EP1618384A2 (en) 2003-04-28 2006-01-25 Wyeth Methods utilising g-protein coupled receptor 54
WO2004101747A2 (en) 2003-05-07 2004-11-25 The General Hospital Corporation Identification and use of gpr54 and its ligands for reproductive disorders and contraception
WO2004106289A1 (en) 2003-05-30 2004-12-09 Prozymex A/S Protease inhibitors
CA2544473C (en) 2003-11-03 2013-08-13 Beijing Sunbio Biotech Co., Ltd. A recombinant protein having an anti-cancer effect, its encoding gene and uses thereof
RU2333221C2 (ru) 2003-11-03 2008-09-10 Бейцзин Санбио Байотек Ко., Лтд. Рекомбинантный белок, обладающий противораковым действием, кодирующий его ген и его применение
WO2005095973A2 (en) 2004-03-25 2005-10-13 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 54 (gpr54)
CA2562676A1 (en) 2004-04-23 2005-12-15 Applied Research Systems Ars Holding N.V. Use of gpcr54 ligands for the treatment of infertility
JP4346650B2 (ja) * 2004-06-25 2009-10-21 武田薬品工業株式会社 メタスチン誘導体およびその用途
WO2007084211A2 (en) 2005-11-11 2007-07-26 The General Hospital Corporation Use of gpr54 ligands for treatment of reproductive disorders, proliferative disorders, and for contraception
US20090093615A1 (en) * 2005-12-22 2009-04-09 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
TWI386417B (zh) * 2005-12-22 2013-02-21 Takeda Pharmaceutical 轉移抑素衍生物及其用途
US8404643B2 (en) * 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
US20090099334A1 (en) * 2005-12-22 2009-04-16 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
CN101443356A (zh) 2006-03-20 2009-05-27 默克公司 神经介肽u受体激动剂及其用途
EP2004216A4 (en) * 2006-03-28 2012-02-01 Molecular Discovery Systems AGENT FOR THE TREATMENT OF HORMONO-DEPENDENT DISORDERS AND USES THEREOF
TWI404726B (zh) 2006-10-25 2013-08-11 Takeda Pharmaceutical 腫瘤轉移抑制素衍生物及其用途
JPWO2009044918A1 (ja) * 2007-10-05 2011-02-17 武田薬品工業株式会社 ニューロメジンu誘導体
US20110118172A1 (en) * 2008-04-24 2011-05-19 Takeda Pharmaceutical Company Limited Metastin derivative and use thereof
EP2340047A1 (en) 2008-09-19 2011-07-06 Nektar Therapeutics Polymer conjugates of kiss1 peptides

Similar Documents

Publication Publication Date Title
JP2008506632A5 (cg-RX-API-DMAC10.html)
FIC20253005I1 (fi) Seladelpaarin L-lysiinisuola, erityisesti seladelpaari-L-lysiinidihydraatti
JP2010501534A5 (cg-RX-API-DMAC10.html)
JP2006526031A5 (cg-RX-API-DMAC10.html)
JP2007522220A5 (cg-RX-API-DMAC10.html)
JP2005518413A5 (cg-RX-API-DMAC10.html)
DK1902037T3 (da) 2,4-diamino-pyrimidiner som auroainhibitorer
NL300703I2 (nl) Simeprevir, of een farmaceutisch aanvaardbaar zout daarvan, waaronder simeprevirnatrium.
JP2010500116A5 (cg-RX-API-DMAC10.html)
JP2008514563A5 (cg-RX-API-DMAC10.html)
JP2006524283A5 (cg-RX-API-DMAC10.html)
JP2006503588A5 (cg-RX-API-DMAC10.html)
JP2009520682A5 (cg-RX-API-DMAC10.html)
ATE477257T1 (de) Piperidinylamino-thienoä2,3-dü- pyrimidinverbindungen
NO20052884D0 (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
SI1725218T1 (sl) Farmacevtski sestavek, ki obsega pimobendan
NO20053762D0 (no) Kondensert furanforbindelse.
JP2007520206A5 (cg-RX-API-DMAC10.html)
JP2007119504A5 (cg-RX-API-DMAC10.html)
JP2004149545A5 (cg-RX-API-DMAC10.html)
JP2007520565A5 (cg-RX-API-DMAC10.html)
ATE531717T1 (de) Neue kristalline form eines pyridazinoä4,5- büindolderivats
JP2006339594A5 (cg-RX-API-DMAC10.html)
JP2003160581A5 (cg-RX-API-DMAC10.html)
NL1031335A1 (nl) Gesubstitueerde N-sulfonylaminofenylethyl-2-fenoxyaceetamideverbindingen.